S3 Ep12: Laugh for Life
Cancer Horizons4 Mars 2020

S3 Ep12: Laugh for Life

Each year, the Multiple Myeloma Research Foundation (MMRF) hosts its Laugh for Life event, which aims to educate, empower and inspire individuals to raise awareness and funds for multiple myeloma research. Ahead of its even, CURE spoke with Tina Rettig, a caregiver for her husband,d who was diagnosed with multiple myeloma in 2010. Tina serves as a co-chair for the event, which will be held on May 6, help to fund groundbreaking research initiatives like the MMRF’s most recent Direct to Patient Registry, a cornerstone of its CureCloud. “One of the big takeaways from (Laugh for Life) is the information that we put out there…(It raises) money, and money leads to research, and research leads to testing new treatments that can be approved,” Rettig said. “And there's no one treatment that fits everybody. So it's important that we have different levels of treatment, and that you can (live with) this disease.” In addition, we spoke with Andrew Marcelle, and his father, Peter, who was diagnosed with multiple myeloma in 2016. Marcell will be receiving the “Spirit of Hope” award at this year’s event for his work in fundraising for the MMRF. “It's such a big organization and there's so many people involved with it…(receiving this award) is very humbling and I'm excited for the event,” Marcelle said. For more information, visit themmrf.org.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Dec 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mars 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mars 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mars 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Feb 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Feb 20247min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
medicinvetarna
svd-nyhetsartiklar
bildningspodden
det-morka-psyket
rss-ufobortom-rimligt-tvivel
rss-spraket
rss-vetenskapsradion
rss-vetenskapsradion-2
sexet
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
rss-kriminologerna
dumforklarat
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
vetenskapsradion
rss-lara-fran-larda-en-fackbok-och-en-forfattare
doden-hjarnan-kemisten